Bard explains endoscopy divestiture
This article was originally published in The Gray Sheet
Executive Summary
"Looking forward, since we do not plan on entering the durable equipment market for products such as endoscopes and electrosurgery generators, we believe our growth potential for the divested products would remain limited," CEO Tim Ring says, clarifying his remarks at the recent Bear Stearns Healthcare Conference in New York. At the event, Ring justified the August sale of endoscopic disposable technology to Conmed for $80 mil. 1("The Gray Sheet" Sept. 27, 2004, p. 13)...